Jay Timmons, NAM CEO

Drug man­u­fac­tur­ers are fight­ing mad about pric­ing leg­is­la­tion and they're tak­ing the next round pub­lic

While drug pric­ing re­form is snaking its way through Con­gress, the pro­posed leg­is­la­tion is fac­ing some op­po­si­tion from in­dus­try groups, as the Na­tion­al As­so­ci­a­tion of Man­u­fac­tur­ers is tak­ing the fight to the air­waves.

The trade group, the Na­tion­al As­so­ci­a­tion of Man­u­fac­tur­ers (NAM), has re­leased a 30-sec­ond ad that firm­ly op­pos­es price con­trols, call­ing them a “hid­den tax on man­u­fac­tur­ers that harms in­no­va­tion, com­pet­i­tive­ness and R&D in­vest­ments in new cures.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.